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Abstract: Studies have found both genetic and environmental influences on chronic 
periodontitis. The purpose of this study was to examine the relationships among previously 
identified genetic variants, smoking status, and two periodontal disease-related phenotypes 
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(PSR1 and PSR2) in 625 Caucasian adults (aged 18–49 years). The PSR Index was used to 
classify participants as affected or unaffected under the PSR1 and PSR2 phenotype 
definitions. Using logistic regression, we found that the form of the relationship varied by 
single nucleotide polymorphism (SNP): For rs10457525 and rs12630931, the effects of 
smoking and genotype on risk were additive; whereas for rs10457526 and rs733048, 
smoking was not independently associated with affected status once genotype was taken 
into consideration. In contrast, smoking moderated the relationships of rs3870371 and 
rs733048 with affected status such that former and never smokers with select genotypes 
were at increased genetic risk. Thus, for several groups, knowledge of genotype may refine 
the risk prediction over that which can be determined by knowledge of smoking status 
alone. Future studies should replicate these findings. These findings provide the foundation 
for the exploration of novel pathways by which periodontitis may occur. 
Keywords: adult; chronic periodontitis; genetics; genomics; smoking 
 
1. Introduction 
Chronic periodontitis is prevalent in the United States, with over one third of the dentate adult 
population having the disease [1]. People with chronic periodontitis can have problems chewing food 
and may ultimately experience tooth loss. Risk factors include the presence of oral pathogens that 
cause periodontal disease, variations to the host’s inflammatory response that may be genetically 
determined [2], and exposure to environmental factors such as smoking [3,4]. Among younger adults 
in particular, smoking appears to be associated with greatly increased risk of chronic periodontitis.  
In the National Health and Nutrition Examination Survey III, compared with nonsmokers, current 
smokers aged 20–49 years were 18.55 times as likely to have an average loss of attachment  
(i.e., reduction in the connective tissue attaching the root of the tooth to the alveolar bone) of 3 mm or 
more (95% CI 9.44–36.45; [5]). For the 10% of younger adults with the greatest loss of attachment, the 
adjusted population attributable fraction due to current smoking was 60% [5]. Thus, smoking plays an 
important role in the etiology of periodontal disease in younger adults.  
Yet, as described above, smoking alone does not cause periodontal disease; pathogens and genetics 
also play roles. However, for the genotypes associated with chronic periodontitis, the relationship of 
those genotypes with smoking remains unknown at this time. There are three possible forms the 
relationship could take [6]. First, smoking and genes could contribute to separate causal pathways  
in chronic periodontitis (i.e., additive effects). Second, smoking could up- or down-regulate the 
expression of genes that cause chronic periodontitis (i.e., mediation); or genes could increase the 
probability of smoking, causing chronic periodontitis (i.e., mediation). And third, smoking could cause 
chronic periodontitis in some people but not others, depending on their genes (moderation;  
see [7,8] for examples). Furthermore, the association between smoking and chronic periodontitis could 
differ depending on the genotype. Identifying the relationship between periodontally-related gene 
variants and smoking could help in assessing risk, targeting interventions to minimize disease risk, and 
improving the treatment of chronic periodontitis.  
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In the present study using data from an observational study of younger adults, we assessed the 
association of smoking with a non-clinical indicator of periodontal health in the context of five 
locations in the genome where the allele tends to differ across people (i.e., genotyped single nucleotide 
polymorphisms; SNPs) we previously identified in a genome-wide association scan (GWAS) of the 
same non-clinical indicator of periodontal health [9]. The phenotype is calculated from Periodontal 
Screening and Recording (PSR) index measures, which are non-clinical measures related to 
periodontal disease. The PSR index measures the depth of the periodontontal pocket from the free 
gingival margin to the bottom of the gingival sulcus. Clinical attachment level, the clinical measure of 
periodontal disease, measures the depth of the periodontal pocket from the cementoenamel junction to 
the bottom of the gingival sulcus. When the gingiva is not affected by either gingival inflammation or 
gingival recession, the free gingival margin and the cementoenamel junction will be the same, and the 
PSR index will provide an accurate measure of clinical attachment level. However, in cases where the 
gingiva is either inflamed or has receded, the free gingival margin and the cementoenamel junction 
will not be the same, and thus the PSR measure of the pocket will be inaccurate. In persons with 
gingival inflammation, it may overestimate disease, and in persons with severe gingival recession, it 
may underestimate disease [10]. Therefore, we view our phenotype as a measure of periodontal health 
and not a measure of chronic periodontitis. 
2. Results and Discussion 
2.1. Demographic and Descriptive Information about the Sample 
The total sample size was 625 (63.8% female), with a mean age of 33.7 years (SD = 7.7, Min = 18, 
Max = 48.9). Using the PSR1 definition of disease, 94 participants were classified as affected (15.0%); 
whereas using the PSR2 definition of disease, 174 participants were classified as affected (27.8%).  
The two approaches to classifying disease resulted in different classifications for 80 participants 
(12.8% of the total sample). Using either PSR1 or PSR2, being affected was associated with  
greater age (Table 1). 
Table 1. Results of logistic regression analyses relating age and smoking to PSR1 and PSR2. 
  PSR1 PSR2 
Predictor Level OR 95% CI Wald χ2 a OR 95% CI Wald χ2 a 
Age 10 year increments 1.35 1.01–1.81 4.04 * 1.59 1.25–2.01 14.57 *** 
        
Smoking Never 1.00  3.29 1.00  13.29 ** 
 Former 1.07 0.60–1.92  1.15 0.72–1.84  
 Current 1.57 0.92–2.70  2.13 1.36–3.31  
Note: Age was included as a covariate in the smoking model. PSR1 = missingness in completely 
edentulous sextants is attributed to causes other than periodontal disease. PSR2 = missingness in 
completely edentulous sextants is attributed to periodontal disease; * p < 0.05; ** p < 0.001;  
*** p < 0.0001; a Degrees of freedom = 1 for age and 2 for smoking. 
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With respect to smoking, 200 (32.0%) participants never smoked; 193 (30.9%) participants were 
former smokers; and 232 (37.1%) participants were current smokers. Among current smokers, the 
average number of cigarettes smoked per week was 94.9 (SD = 59.9). Table 1 and Figure 1 present the 
relationship between smoking status and disease status. As expected, relative to never smokers, current 
smokers had higher odds of having disease (Table 1). Odds of having disease did not differ between 
former smokers and never smokers; therefore, for analyses below, we collapse former and never 
smokers into one category. 
Figure 1. Relationship of smoking status with PSR1 and PSR2. 
 
Note: PSR1 = missingness in completely edentulous sextants is attributed to causes other than 
periodontal disease. PSR2 = missingness in completely edentulous sextants is attributed to 
periodontal disease. 
2.2. Results Supporting an Additive Relationship 
In our previous study [9], we found an association between PSR1 and rs10457525. When PSR1 was 
predicted by age, smoking status, and rs10457525 genotype simultaneously, age in 10-year increments 
(OR = 1.46, 95% CI = 1.07 to 1.98), smoking status (OR = 1.62, 95% CI = 1.02 to 2.59), and genotype 
(GG vs. TT: OR = 0.17, 95% CI = 0.07 to 0.40; TG vs. TT: OR = 0.34, 95% CI = 0.14 to 0.82) each 
accounted for unique variance in the outcome.  
Similarly, in our previous study, we found an association between PSR2 and rs12630931.  
When PSR2 was predicted by age, smoking status, and rs12630931 genotype simultaneously, age in 
10-year increments (OR = 1.71, 95% CI = 1.33 to 2.20), smoking status (OR = 2.00, 95% CI = 1.37  
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to 2.93), and genotype (CC vs. TT: OR = 3.54, 95% CI = 1.87 to 6.69; CT vs. TT: OR = 1.86,  
95% CI = 1.26 to 2.74) each accounted for unique variance in the outcome.  
For neither rs10457525 nor rs12630931 was the effect of genotype moderated by an interaction 
with smoking status. Using Chi-square analysis, neither SNP was related to smoking status.  
Thus, genotype does not mediate the association of affected status with smoking status; and smoking 
status does not mediate the association of affected status with genotype. Thus, for both rs10457525 and 
rs12630931, an additive model with smoking best described the relationship with PSR1 or PSR2.  
To the best of our knowledge, none of the genes near these SNPs produces a protein known to be 
related to periodontal disease or its two major risk factors, smoking and diabetes. 
2.3. Results Supporting a Unique Relationship for Genotype but Not Smoking Status 
In our previous study, we found an association between PSR1 and rs10457526. When PSR1 was 
predicted by age, smoking status, and rs10457526 genotype simultaneously, age in 10-year increments 
(OR = 1.47, 95% CI = 1.08 to 2.00) and genotype (GG vs. TT: OR = 0.14, 95% CI = 0.06 to 0.32;  
TG vs. TT: OR = 0.26, 95% CI = 0.11 to 0.59) each accounted for unique variance in the outcome, and 
smoking status marginally accounted for variance (OR = 1.55, 95% CI = 0.97 to 2.47).  
Similarly, in our previous study, we found an association between PSR1 and rs733048. When PSR1 
was predicted by age, smoking status, and rs733048 genotype simultaneously, age in 10-year 
increments (OR = 1.42, 95% CI = 1.05 to 1.93) and genotype (AA vs. GG: OR = 4.46, 95% CI = 1.93 
to 10.29; AG vs. GG: OR = 2.23, 95% CI = 1.40 to 3.57) each accounted for unique variance in the 
outcome, and smoking status was not associated.  
For neither rs10457526 nor rs733048 was the effect of genotype moderated by an interaction with 
smoking status. Using Chi-square analysis, neither SNP was related to smoking status. Thus, genotype 
does not mediate the association of affected status with smoking status; and smoking status does not 
mediate the association of affected status with genotype. Thus, for rs10457526 and rs733048 using the 
PSR1 definition, smoking was no longer associated with the outcome once genotype was taken into 
consideration. To the best of our knowledge, none of the genes near these SNPs produces a protein 
known to be related to periodontal disease or its two major risk factors, smoking and diabetes.  
2.4. Results Supporting an Interaction of Genotype by Smoking Status 
In our previous study, we also found an association between PSR2 and rs733048. When PSR2 was 
predicted by age, smoking status, and rs733048 genotype simultaneously, they each accounted for 
unique variance in the outcome. However, the main effect of the rs733048 genotype on affected status 
was moderated by an interaction with smoking status (Wald χ2 (df = 2) = 10.05, p < 0.007; Figure 2). 
Among those with the GG genotype, as expected, never and former smokers were less likely than 
current smokers to be cases (OR = 0.30, 95% CI = 0.18 to 0.50). However, among those with either the 
AA or the AG genotypes, current smoking was not associated with an increased or decreased risk of 
being a case relative to never smoking or formerly smoking. To determine whether having the AA or 
AG genotypes protected current smokers or increased the risk of former and never smokers, we 
examined the interaction the other way. Relative to having the GG genotype, having the AA genotype 
(OR = 3.73, 95% CI = 1.30 to 10.74) or the AG genotype (OR = 3.60, 95% CI = 2.17 to 5.97) was 
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associated with an increased risk among never and former smokers. Relative to having the GG 
genotype, having the AA (OR = 2.22, 95% CI = 0.69 to 7.13) or AG genotype (OR = 1.03, 95%  
CI = 0.57 to 1.85) was not associated with increased risk among current smokers. Thus, having either 
the AA or AG genotypes was associated with an increased risk of having disease among former and 
never smokers. 
Figure 2. Percents of persons within groups defined by both smoking status and rs733048 
genotype who are affected (PSR2). 
 
Note: N’s refer to number of affected individuals with the genotype and smoking status. 
In our previous study, we found an association between PSR1 and rs3870371. When PSR1was 
predicted by age, smoking status, and rs3870371 genotype simultaneously, age and genotype 
accounted for unique variance in the outcome and smoking status was not associated. However, the 
main effect of the rs3870371genotype on case status was moderated by an interaction with smoking 
status (Wald χ2 (df = 2) = 5.65, p < 0.06; Figure 3). Among those with the CC genotype, as expected, 
never and former smokers were less likely than current smokers to be cases (OR = 0.34, 95% CI = 0.15 
to 0.77). However, among those with either the AA or the AC genotypes, current smoking was not 
associated with an increased or decreased risk relative to never smoking or formerly smoking.  
To determine whether having the AA or AC genotypes protected current smokers or increased the risk 
of former and never smokers, we examined the interaction the other way. Relative to having the CC 
genotype, having the AA genotype (OR = 4.35, 95% CI = 1.68 to 11.25) or the AC genotype  
(OR = 3.74, 95% CI = 1.85 to 7.58) was associated with an increased risk among never and former 
smokers. Relative to having the CC genotype, having the AA genotype (OR = 2.85, 95% CI = 1.05  
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to 7.73) was associated with an increased risk among current smokers. Relative to having the  
CC genotype, having the AC genotype was not associated with an increased or decreased risk among 
current smokers. Thus, having either the AA or AC genotypes was associated with an increased risk 
among former and never smokers and having the AA genotype was associated with an increased risk 
among current smokers.  
Figure 3. Percents of persons within groups defined by both smoking status and rs3870371 
genotype who are affected (PSR1). 
 
Note: N’s refer to number of affected individuals with the genotype and smoking status. 
Using Chi-square analysis, neither SNP was related to smoking status. Thus, genotype does not 
mediate the association of affected status with smoking status; and smoking status does not mediate the 
association of affected status with genotype. 
Thus, the relationship of rs733048 with PSR2 was moderated by smoking. Among people with the 
GG genotype, the relationship between smoking and risk was as expected: current smoking was 
associated with higher risk. However, having either the AA or AG genotypes was associated with an 
increased risk among former and never smokers. This identifies two new groups of people at higher 
risk. Similarly, the relationship of rs3870371 with PSR1 was moderated by smoking. Among people 
with the CC genotype, the relationship between smoking and risk was as expected: current smoking 
was associated with higher risk. However, having either the AA or AC genotypes was associated with 
an increased risk among former and never smokers and having the AA genotype was associated with 
an increased risk among current smokers. This identifies three new groups of people at higher risk. 
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Although none of the genes near rs733048 is known to be related to periodontal disease or its two 
major risk factors, smoking and diabetes, there are two genes, HAS2 and HAS2AS, near rs3870371 
that have previously-documented relationships with the periodontium. They are both related to wound 
healing [11,12]. 
3. Experimental Section  
3.1. Participant Recruitment 
As previously described [13], the study population was drawn from four, economically distressed, 
rural counties in northern West Virginia and western Pennsylvania in which the Center for Oral Health 
Research in Appalachia is active. Families were eligible if they had at least one adult and at least one 
child between the ages of 1 and 18 biologically-related to that adult who lived together; recruitment 
was not based on oral health status. Using these criteria, we were able to recruit 650 families. Once a 
family was recruited, everyone living in the household was invited to participate, regardless of 
biological or legal relationship. Written informed consent was obtained from all adult participants.  
All study procedures and consent forms were approved by the Institutional Review Boards of the 
University of Pittsburgh and West Virginia University.  
3.2. Phenotype and Covariate Assessment 
Participants received a comprehensive orodental examination by a licensed dentist or  
dental hygienist in a well equipped, modern dental operatory. Data for each study participant included 
periodontal status and history, medical history, health behaviors, social adjustment,  
demographics (ethnicity, SES, etc.), and DNA source (blood, saliva). As previously described [9], to 
assess periodontal status, a modified Periodontal Screening and Recording (PSR) procedure [14] was 
performed as follows. Except for third molars, which were excluded, every tooth was evaluated.  
The mouth was divided into sextants, and the probing depth for the deepest pocket in each sextant was 
recorded. If all teeth in a given sextant were missing (i.e., the sextant was completely edentulous),  
no observation was recorded for that sextant. Because the reasons why the teeth were missing were 
unknown, we created two definitions of disease. In the PSR1 definition of disease, teeth in edentulous 
sextants were treated as though they had not had periodontal disease (i.e., pocket probing depth less 
than 5.5 mm). In the PSR2 definition of disease, teeth in edentulous sextants were treated as though 
they had had disease (i.e., pocket probing depth of at least 5.5 mm). Affected persons were defined as 
persons with at least two sextants with a pocket probing depth of at least 5.5 mm or self-reported “gum 
surgery” (n = 14). Persons not classified as affected were classified as unaffected.  
To assess smoking, we asked the following questions “Please indicate which drugs you have ever 
tried for recreation by circling yes. If you have never tried the drug, skip to the next drug on the list. 
DR02–smoking tobacco (Cigarettes, Pipes, Cigars)” from the Drug Use Screening Inventory-Revised 
(DUSI-R; [15]) and “Are you currently a daily cigarette smoker?”. From these two questions, we were 
able to distinguish never, former, and current smokers. We compared urinary and salivary cotinine 
levels as assayed by NicAlert strips to self-reported smoking status in 59 adults with no incentive to 
lie. There was 90% and 86% agreement between self-report and urinary or salivary cotinine, respectively.  
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Genotyping, imputation, and quality control have been previously described [9]. To reduce Type I 
error due to population stratification, the sample on which the GWAS was conducted was limited to 
self-reported non-Hispanic Caucasians only.  
3.3. Data Analysis 
To minimize the risk of an inflated type I error due to misclassifying non-diseased persons as 
having disease, we excluded from our analyses persons who were pregnant (n = 13) or who reported 
taking medications that could result in gingival hyperplasia or edema including birth control pills  
(n = 24), estrogen replacement therapy (n = 3), calcium channel blockers (n = 1), or Dilantin (n = 4). 
GWAS analysis identified 11 SNPs having suggestive associations with either PSR1 or PSR2 (9).  
In the present study, we examined only those five SNPs that were genotyped and not those that were 
imputed (see Table 2). 
Table 2. Genotyped SNPs identified by GWAS. 
SNP 
Outcome 
Associated With 
Strength of 
Association 
Chromosome, 
Coordinate 
Nearby Genes 
rs10457525 PSR1 5.72 × 10−07 6, 129872966 LAMA2, ARHGAP18 (SENEX) 
rs733048 PSR1 1.07 × 10−06 4, 13242797 HSP90AB2P, RAB28, BOD1L, 
NKX3-2 
rs10457526 PSR1 1.17 × 10−06 6, 129896501 LAMA2, ARHGAP18 (SENEX) 
rs733048 PSR2 6.15 × 10−06 4, 13242797 HSP90AB2P, RAB28, BOD1L, 
NKX3-2 
rs12630931 PSR2 7.32 × 10−06 3, 31981767 OSBPL10, ZNF860, GPD1L, 
CMTM8, STT3B 
rs3870371 PSR1 8.79 × 10−06 8, 122697132 HAS2, HAS2AS 
To examine additive effects of smoking status (current versus never and former) and each of the 
selected SNPs, we included both smoking status and SNP genotype in logistic regression models 
simultaneously, covarying age. Predictors were considered to account for unique variance in affected 
status (i.e., additive effects) if they were associated with being affected at p < 0.05. To test for 
mediation, we first examined whether smoking status (current versus never and former) was associated 
with each of the selected SNPs. Using Chi-square analysis, none of the SNPs was related to smoking 
status. Thus, we were able to rule out both forms of mediation. To examine the ability of smoking 
status (current versus never and former) to moderate the relationship between genotype (AA, Aa, and 
aa) and affected status (affected versus unaffected), we used logistic regression covarying age and 
main effects. In our power calculations for PSR1, we could achieve 15–80% power for interactions by 
making assumptions for parameters based on what we observed in our study (e.g., sample size, allele 
frequency, disease prevalence, and effect sizes for the SNPs and smoking). For PSR2, we could 
achieve 29–96% power for interactions. Because in the GWAS [9], four of the five SNPs were 
associated with either PSR1 or PSR2 but not both, for those SNPs, we examined pathways with only 
the disease definition for which the association had been observed. Because this was an exploratory 
study, no correction was made for multiple comparisons.  
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3.4. Missing Data 
Genotyping was available for 694 participants. Due to missing values on smoking status,  
69 participants were excluded from analyses involving smoking status. 
4. Conclusions  
Smoking is a known risk factor for chronic periodontitis [3] and as expected, in our sample, current 
smoking was associated with having at least two sextants with periodontal probing depths exceeding 
5.5 mm. Furthermore, we determined the relationship between genotypes previously identified as 
being associated with periodontal probing depths exceeding 5.5 mm in this sample and smoking.  
For rs10457525 under the PSR1 definition of affected status and rs12630931 under the PSR2 
definition of affected status, we demonstrated that the effects of smoking and genotype on risk were 
additive. For rs10457526 and rs733048 under the PSR1 of affected status, smoking was no longer 
associated with having periodontal probing depths exceeding 5.5 mm once genotype was taken into 
consideration. Finally, we found that smoking moderated the relationships of rs3870371 under the 
PSR1 definition and rs733048 under the PSR2 definition with affected status. Thus, for several groups 
of people, knowledge of genotype may refine the risk prediction over that which can be determined by 
knowledge of smoking status alone. This is consistent with other studies that have also obtained 
evidence that smoking moderates the relationship between genotype and periodontal disease [3].  
Strengths and Limitations 
This study has several strengths and limitations. One strength of the study is that we examined three 
possible relationships genotype and smoking could have with affected status. The study had some 
limitations as well. First, the phenotype was defined based on measurement of the PSR index, which is 
a non-clinical measure related to periodontal disease. In addition, there could be misclassification error 
due to missing teeth, although we attempted to address this issue by using two definitions. Future 
studies should improve the definition of the phenotype. Finally, we may have had low power to detect 
interactions. Future studies should include more affected persons. 
In this study, we determined the relationships between SNPs, smoking status, and affected status. 
By doing this, we identified several groups that were at higher risk than would have been predicted 
from their smoking status alone. These findings are significant, because they provide the foundation 
for more precise risk assessment and the identification of new preventive and treatment interventions. 
Future studies should confirm the pathways we observed in the present study.  
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